Biotech investors brace for updates on key drugs By: CNBC.com News April 17, 2015 at 13:44 PM EDT Biotech investors are going to be busy with new data on Alzheimer's drugs, cancer and genetic disorders on the way. Here's what analysts are watching. Read More >> Related Stocks: Alnylam Pharmaceuticals Bellicum Pharmaceuticals Inc Biogen Idec Bristol-Myers Squibb Citigroup Incyte Corp Infinity Pharmaceuticals Merck & Co Novartis Ag ADR Ptc Therapeutics Ziopharm Oncology IN
